Iceland vs Saint Lucia: Tuberculosis patients living with HIV receiving antiretroviral therapy
Iceland
0 patients
in 2014
Saint Lucia
0 patients
in 2021
Iceland rank
141st
Saint Lucia rank
141st
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Iceland
- Saint Lucia
How they compare
Iceland currently reports 0 patients against 0 patients in Saint Lucia, a difference of 0 patients.
The two have swapped places 1 time across 9 shared years of data; in 2003 it was Iceland ahead.
Iceland ranks 141st and Saint Lucia ranks 141st of 183 countries.
Across the 2 decades both report, Iceland averaged higher in 1 and Saint Lucia in 1.
Head to head by decade
| Decade | Iceland | Saint Lucia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.5 patients | 0.25 patients | 0.25 patients | Iceland |
| 2010s | 0 patients | 0.6 patients | 0.6 patients | Saint Lucia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Iceland or Saint Lucia?
- Iceland, at 0 patients against 0 patients in Saint Lucia as of 2014.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Iceland and Saint Lucia?
- 0 patients, with Iceland ahead.
- How many years of comparable data are there for Iceland and Saint Lucia?
- 9 years are reported by both, from 2003 to 2014.
- How do Iceland and Saint Lucia rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Iceland ranks 141st and Saint Lucia ranks 141st of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.